DoubleLine ETF Adviser’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-45,267
Closed -$3.58M 182
2025
Q4
$3.58M Buy
45,267
+4,082
+10% +$320K 1.07% 27
2025
Q3
$3.29M Buy
+41,185
New +$3.51M 0.99% 37
2025
Q2
Sell
-37,253
Closed -$3.49M 161
2025
Q1
$3.49M Sell
37,253
-5,343
-13% -$478K 1.16% 25
2024
Q4
$3.87M Buy
42,596
+1,089
+3% +$104K 1.04% 29
2024
Q3
$4.31M Buy
41,507
+8,483
+26% +$865K 1.05% 26
2024
Q2
$3.2M Sell
33,024
-2,633
-7% -$243K 0.84% 33
2024
Q1
$3.21M Buy
+35,657
New +$3.02M 0.82% 35
2023
Q4
Sell
-28,496
Closed -$2.03M 208
2023
Q3
$2.03M Buy
+28,496
New +$2.13M 0.73% 32

Other funds holding CL

DoubleLine ETF Adviser's CL Position: Q1 2026 in Review

DoubleLine ETF Adviser sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 45,267 shares — an estimated $3.58M sold.

DoubleLine ETF Adviser first reported a position in CL in Q3 2023 and held it in 8 quarters. The position peaked at $4.31M in Q3 2024. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • DoubleLine ETF Adviser reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
  • DoubleLine ETF Adviser sold 45,267 Colgate-Palmolive shares in Q1 2026, an estimated $3.58M.
  • DoubleLine ETF Adviser first reported a position in Colgate-Palmolive in Q3 2023 and held it in 8 quarters.
  • DoubleLine ETF Adviser's Colgate-Palmolive position peaked at $4.31M in Q3 2024.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on DoubleLine ETF Adviser's 13F filing for Q1 2026, filed 15 May 2026.